Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption

Journal of Hypertension

Volumn 30, Issue 7, 2012, Pages 1453-1459

  Fukuda, Michio ^a   Urushihara, Maki ^b   Wakamatsu, Tamaki ^a   Oikawa, Tadashi ^a   Kobori, Hiroyuki ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

angiotensinogen; blood pressure; circadian rhythm; immunohistochemistry; sodium

Indexed keywords

ANGIOTENSINOGEN; CREATININE;

ADULT; ARTICLE; BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY PROXIMAL TUBULE; MALE; NONDIPPER CIRCADIAN BLOOD PRESSURE RHYTHM; PRIORITY JOURNAL; SODIUM ABSORPTION;

EID: 84862762294     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328353e807     Document Type: Article

References (35)

1. O'Brien E, Sheridan J, O'Malley K. Dippers and nondippers. Lancet 1988; 2:397.
2. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of nondipper pattern of circadian blood pressure rhythm. Med Hypotheses 2006; 67:802-806. (Pubitemid 44096890)
3. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension 2008; 52:1155-1160.
4. Kimura G, Brenner BM. The renal basis for salt sensitivity in hypertension. In Laragh JH, Brenner BM, editors. Hypertension pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. pp. 1569-1588.
5. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65:621-625. (Pubitemid 38130657)
6. Kuroda S, Uzu T, Fujii T, Nishimura M, Nakamura S, Inenaga T, Kimura G. Role of insulin resistance in the genesis of sodium sensitivity in essential hypertension. J Hum Hypertens 1999; 13:257-262. (Pubitemid 29187007)
7. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999; 100:1635-1638. (Pubitemid 29477273)
8. Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators. J Hypertens 2005; 23:861-865. (Pubitemid 40523286)
9. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001; 12:431-439. (Pubitemid 32180011)
10. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001; 37:1329-1335. (Pubitemid 34163590)
11. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal reninangiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-287. (Pubitemid 47481436)
12. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992; 263 (5 Pt 1):E863-E869.
13. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol 1999; 276 (2 Pt 2):F218-F227. (Pubitemid 29102286)
14. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004; 43:1126-1132. (Pubitemid 38579925)
15. Schuster VL, Kokko JP, Jacobson HR. Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 1984; 73:507-515. (Pubitemid 14194631)
16. Olsen ME, Hall JE, Montani JP, Guyton AC, Langford HG, Cornell JE. Mechanisms of angiotensin II natriuresis and antinatriuresis. Am J Physiol 1985; 249 (2 Pt 2):F299-F307. (Pubitemid 16245322)
17. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002; 13:1131-1135. (Pubitemid 34441392)
18. Braam B, Navar LG, Mitchell KD. Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension. Hypertension 1995; 25:1232-1237.
19. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT1 receptor. Hypertension 2002; 39:116-121. (Pubitemid 34098099)
20. Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, et al. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens 2008; 26:583-588. (Pubitemid 351317269)
21. Fukuda M, Wakamatsu-Yamanaka T, Mizuno M, Miura T, Tomonari T, Kato Y, et al. Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption. Am J Physiol Renal Physiol 2011; 301:F953-F957.
22. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13:142-148. (Pubitemid 34042021)
23. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, et al., Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76:534-545.
24. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003; 41:42-49. (Pubitemid 36056790)
25. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999; 34:1265-1274. (Pubitemid 30002393)
26. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 1997; 272:F405-F409.
27. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971; 5:86-89.
28. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 1996; 27:465-475. (Pubitemid 26086217)
29. Guyton AC. Arterial pressure and hypertension. Circulatory physiology III. Philadelphia: WB Saunders; 1980.
30. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension 1990; 15 (6 Pt 1):547-559. (Pubitemid 20187599)
31. Kimura G, Imanishi M, Sanai T, Kawano Y, Kojima S, Yoshida K, et al. Intrarenal hemodynamics in patients with essential hypertension. Circ Res 1991; 69:421-428.
32. Gomez DM. Evaluation of renal resistances, with special reference to changes in essential hypertension. J Clin Invest 1951; 30:1143-1155.
33. Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, et al. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 2007; 358: 156-163. (Pubitemid 46719097)
34. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797-805. (Pubitemid 34988338)
35. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, et al. ROADMAP Trial Investigators. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011; 364:907-917.